Novabase S.G.P.S' stock has risen by 2.6% in the past three months. Despite this, the company's financial health is not promising, with a low ROE of 4.6%.
Read MoreDid you find this insightful?
Amazing
Bad
Just Okay
Novabase S.G.P.S' stock has risen by 2.6% in the past three months. Despite this, the company's financial health is not promising, with a low ROE of 4.6%.
Read MoreDid you find this insightful?
Amazing
Bad
Just Okay